Ergoteles’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22,262
| Closed | -$900K | – | 1159 |
|
|
2023
Q1 | $900K | Buy |
22,262
+10,386
| +87% | +$420K | 0.04% | 538 |
|
|
2022
Q4 | $552K | Buy |
+11,876
| New | +$552K | 0.02% | 662 |
|
|
2022
Q2 | – | Sell |
-9,809
| Closed | -$698K | – | 1736 |
|
|
2022
Q1 | $698K | Sell |
9,809
-1,339
| -12% | -$95.3K | 0.03% | 547 |
|
|
2021
Q4 | $834K | Buy |
+11,148
| New | +$834K | 0.03% | 473 |
|
|
2021
Q2 | – | Sell |
-11,400
| Closed | -$562K | – | 1541 |
|
|
2021
Q1 | $562K | Buy |
+11,400
| New | +$562K | 0.02% | 465 |
|